Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL9308725

CCCC[N+](CCCC)(CCCC)CCCC.O=S(=O)(O)C(F)(F)F.[F-]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.50
EPHX1 P07099 1/20 0.46
SLC22A2 O15244 1/20 0.44
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
ALOX12 P18054 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HIF1A Q16665 1/20 0.41
HSD17B10 Q99714 1/20 0.41
DNM1 Q05193 2/20 0.38
CES1 P23141 4/20 0.38
FAAH O00519 2/20 0.38
CES2 O00748 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL160606 0.98 SLC22A1 (0.52) SLC22A1EPHX1SLC22A2ALDH1A1TP53
Trifluoromethanesulfonic Acid SCHEMBL302257 0.94 SLC22A1 (0.52) SLC22A1EPHX1SLC22A2ALDH1A1TP53
Tetrapentylammonium SCHEMBL2862365 0.94 SLC22A1 (0.52) SLC22A1EPHX1SLC22A2ALDH1A1TP53
Trifluoromethanesulfonic Acid SCHEMBL2857301 0.92 SLC22A1 (0.54) SLC22A1EPHX1SLC22A2ALDH1A1TP53
Tetrahexylammonium SCHEMBL2862383 0.92 SLC22A1 (0.54) SLC22A1EPHX1SLC22A2ALDH1A1TP53
Tetrabuthylammonium SCHEMBL1363406 0.90 SLC22A1 (0.44) SLC22A1EPHX1SLC22A2ALDH1A1TP53
Trifluoromethanesulfonic Acid SCHEMBL34613 0.89 SLC22A1 (0.43) SLC22A1EPHX1SLC22A2ALDH1A1TP53
Trifluoromethanesulfonic Acid SCHEMBL17180006 0.88 DNM1 (0.56) SLC22A1EPHX1SLC22A2ALDH1A1TP53
Trifluoromethanesulfonic Acid SCHEMBL34569 0.87 SLC22A1 (0.41) SLC22A1EPHX1SLC22A2ALDH1A1TP53
Trifluoromethanesulfonic Acid SCHEMBL3129636 0.87 EPHX1 (0.56) EPHX1HSD17B10CES1FAAHCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5318989-A Antitumor and -carcinogenic agents; antibiotics; aglycones of esperamycins and calichemicins and having the same mechanism of bioactivity BRISTOL-MYERS SQUIBB COMPANY (US) 1994-06-07 US disclosed
EP-0538898-A2 Cytotoxic bicyclo (7.3.1)-tridec-4-ene-2,6-diyne compounds and process for the preparation thereof Bristol-Myers Squibb Company (US) 1993-04-28 EP disclosed
US-5198560-A Antitumor agents based on esperamicin antibiotics BRISTOL-MYERS SQUIBB COMPANY (US) 1993-03-30 US disclosed